International Assets Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
MIH
MSR
PR
SO
WT
International Assets Investment Management's XBI Position: Q2 2026 in Review
International Assets Investment Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 83% in Q2 2026, buying an estimated $94.6K and bringing the position to 1,539 shares worth $241K. The position accounts for 0.01% of the portfolio, ranked #785.
International Assets Investment Management first reported a position in XBI in Q1 2020 and has held it in 10 quarters since. The position peaked at $3.07M in Q2 2020. 551 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- International Assets Investment Management held 1,539 shares of State Street SPDR S&P Biotech ETF worth $241K as of Q2 2026.
- International Assets Investment Management bought 700 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $94.6K.
- State Street SPDR S&P Biotech ETF made up 0.01% of International Assets Investment Management's portfolio in Q2 2026, its #785 holding.
- International Assets Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 10 quarters since.
- International Assets Investment Management's State Street SPDR S&P Biotech ETF position peaked at $3.07M in Q2 2020.
- 551 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.